Biotech industry
-
Upload
dheeraj-prabhakar -
Category
Education
-
view
852 -
download
4
description
Transcript of Biotech industry
Biotechnology
Presented By
Dheeraj
Indian Biotechnology Sector
§ The Biotechnology industry in India to reach $11.6 billion by 2017-Global Industry Analysis.
§ The opportunities for investors in Biotech industry are manifold.
§ In 2010-11 the Indian Biotech industry registered 21.5% growth, touching $4 billion mark clocking Rs 18,399.34 Cr.
§ The Biopharma segment continues to dominate biotech industry with 61.77% share in the overall revenue.
₰ In Asia Pacific market, India occupies 28.66% market share.
₰ India is in 12th rank in the world in biotechnology and 3rd largest in Asia-Pacific after Japan and Korea.
₰ The Sector employees approximately 20,000 scientists and over 352 companies drive it towards further growth.
₰ Karnataka is the Biotech Capital of India
Karnataka-India’s Biotech Hub
₴ The Biotech capital of India.₴ 60% of biotech companies are
having base in Bangalore.₴ 50% of the total revenues in
national biotechnology sector.₴ Growth in industrial output of
Karnataka’s biotech companies CAGR 11% per annum.
₴ Extensive Intellectual Capital– 12 Biotechnology finishing
schools under millennium biotech policy II
– 103 R&D Centers
• Extensive Intellectual Capital– Sector focused SEZs-Mysore,
Mangalore, Hubli-Dharward, Belgaum, Shimoga, Gulbarga,Kolar & Mandya.
– 86 acre Bitochnology park-“Bangalore Helix” with 52 acre Alexandria Knowledge Park in Bangalore.
• Pro Industry policy-State Millennium Biotech Policy II 2010, State Industrial Policy 2009-14– K-Bio Venture capital fund of
US$ 10.4 million with 26% stake holding by GoK
The Indian Biotechnology sector can be divided into the segments of biopharmaceuticals, bioservices, bioagriculture, bioindustrial and bioinformatics.
Nearly 40 percent of the biotech companies operate in the biopharma sector, followed by the bioservices (21 percent), bioagri (19 percent), bioinformatics (14 percent) and lastly the bioindustrial sector (5 percent).
Divisions
Biopharmaceuticals
• This constitutes the largest segment of the Indian biotech industry both in terms of domestic and export revenues.
• About 70 percent of the domestic biotech industry comprises of the Biopharma sector.
• Of the total 325biotechnology companies in India, more than 40 percent are in the biopharma sector.
• Vaccines, therapeutics and diagnostics fall into this category.
Bioservices
• The Bioservices market is the second largest sector of the Indian Biotechnology Industry.
• The market’s growth can be attributed to the fact that India has become a popular destination for clinical trial, contract research and manufacturing activities.
Agricultural Biotechnology
• This segment can be segmented into Hybrid seeds and transgenic crops, Biopesticides and Biofertilizers.
• Genetically modified cotton or commonly known as Bt cotton constitute approximately 77 percent of the revenue of this sector whereas Biopesticides and Biofertilizers together account only for 23 percent of the revenues by agricultural biotechnology.
Bioinformatics / BioIT
• This sector deals with the creation and maintenance of extensive electronic databases on various biological systems and is probably the smallest part of the current domestic biotechnology industry.
• However, India is known for its strong IT base and it is due to this that India is sure to become a leading destination for work in the bioinformatics arena.
Bioindustrial
• This industry predominantly consists of enzyme manufacturing and marketing companies.
• These enzymes are used in industries such as detergents, textiles, food, leather, paper and pharmaceuticals. This generates 6 percent of the revenues of the biotechnology industry.
List of Top Biotech 20 Companies Serum Institute of India Biocon Panacea Biotec Rasi Seeds Nuziveedu Seeds Novo Nordisk India Venkateshwara Hatcheries Indian Immunologicals Mahyco Monsanto Biotech GlaxoSmithKline Pharma Aventis Pharma Shantha Biotechnics Eli Lilly and Company(India) Mahyco Seeds Bharat Serums and Vaccines Novozymes South Asia Invert India Bharat Biotech International Ankur Seeds Advanced Enzyme Technologies
Serum Institute of India
Vaccine King
With a record sales of Rs 950.95 crore in 2010-11,
Serum Institute of India continues to be a leader in the vaccines market.
Business: Manufacturing and marketing of vaccines
and immuno-biologicals
CEO: Dr C S Poonawalla (CMD)
Biotech Revenue: Rs 950.95 crore
Start-up Year: 1966
Address: 212/2, Hadapsar, Off Soli Poonawalla Road,
Pune- 411 028
Biocon
Collective Expertise
Biocon's integrated business approach coupled with its collective expertise has enabled it to establish a
significant presence in the global
biopharmaceutical market.
Business: Biopharmaceuticals and industrial enzymes
CEO: Kiran Mazumdar Shaw
Biotech Revenue: Rs 823 crore
Start-up Year: 1978
Address: 20th KM Hosur Road, Electronic City, Bangalore –
560100
Panacea Biotec
Product Innovation
Panacea Biotec has added new drugs to its product basket like Siropan, Lower A,
Myelogen Forte, Inrica, TOFF Expectorant, Toff DC,
Upright SP and Trepro.
Business: Manufacturer of pharmaceuticals and biopharmaceuticals
CEO: Soshil Kumar Jain (MD)
Biotech Revenue: Rs 600 crore
Start-up Year: 1984
Address: B-1 Extn/G-3, Mohan Co-operative Industrial Estate, Mathura Road, New
Delhi – 110 044
Rasi Seeds
Bt Cotton Maker
Rasi Seeds accounted for 35 percent of the total Bt cotton
seeds sold in India in the year 2011.
Business: Producing and marketing
agri-biotechnology products
CEO: M Ramasami (MD)
Biotech Revenue: Rs 333.33 crore
Start-up Year: 1973
Address: 273, Kamarajanar Road, Attur, Salem - 636 102,
Tamil Nadu
Nuziveedu Seeds
Transgene Developer
Nuziveedu Seeds is working on its own indigenous transgene to combat bollworms and these technologies are expected to
be commercialized soon.
Business: Manufacturer of hybrid cotton seeds
CEO: M Prabhakar Rao
Biotech Revenue: Rs 226.42 crore
Start-up Year: 1973
Address: 7C, Surya Towers, 105 SP Road, Secunderabad – 500
003
Novo Nordisk India
Insulin Leader
Novo Nordisk India enjoys a lion's share in the Indian insulin market.
Novo Nordisk India
CEO: Melvin Oscar D'Souza (MD)
Biotech Revenue: Rs 222 crore
Business: Diabetes care products, human growth hormone and
haemostasis management.
Start-up Year: 1990
Address: 8th Floor, Raheja Towers, East Wing, 26/27, MG Road,
Bangalore- 560 001
Venkateshwara Hatcheries
Poultry Passion
Venkateshwara Hatcheries dominates the Indian poultry vaccines market
with a share of over 60 percent.
Venkateshwara Hatcheries
Business: Engaged in R&D, production and export of vaccines
and diagnostics kits
CEO: Anuradha Desai (Chairperson)
Biotech Revenue: Rs 190.50 crore
Start-up Year: 1971
Address: Venkateshwara House, SN 114/A/2,
Pune - Sinhgad Road,Pune - 411030
Indian Immunologicals
Animal Health Specialist
Indian Immunologicals Ltd (IIL) has bagged the distinction of being the largest exporter of veterinary biological in Asia.
Indian Immunologicals Ltd (IIL)
Business: Manufacturer of animal and human biological
CEO: KV Balasubramaniam
Biotech Revenue: Rs 157.90 crore
Start-up Year: 1983
Address: Road No.44, Jubilee Hills, Hyderabad - 500 033
Mahyco Monsanto Biotech
The Technologist
Mahyco Monsanto Biotech (India), a 50:50 joint venture with Mahyco and
Monsanto Holdings Pvt Ltd (MHPL), was created to bring the benefits of
Bollgard cotton technology to farmers in India.
Mahyco Monsanto Biotech (India)
Business: Marketing of Bt technology in India
CEO: Dr MK Sharma (MD)
Biotech Revenue: Rs 150.30 crore
Start-up Year: 1998
Address: Ahura Centre, 5th Floor, 96, Mahakali Caves Road, Andheri (East),
Mumbai - 400 093
GlaxoSmithKline Pharma
Novel Concepts
With growing competition from the local low-priced products, GSK has initiated novel concepts to bring awareness on the use of
vaccines in the country.
GlaxoSmithkline Pharmaceuticals
Business: Engaged in the sale of vaccines
CEO: Dr Hasit B Joshipura (MD)
Biotech Revenue: Rs 120 crore
Start-up Year: 2001
Address: GSK House, Dr Annie Besant Road, Worli, Mumbai - 400030
Aventis Pharma
Anti-rabies Vaccine Leader
Aventis Pharma leads the anti-rabies vaccine market in India, having a
market share of 60 percent.
Aventis Pharma
Business: Marketing of biotechnology products
CEO: Dr Shailesh Ayyangar (MD)
Biotech Revenue: Rs 119.65 crore
Address: Aventis House, 54/A, Sir Mathuradas Vasanji Road, Andheri
(East), Mumbai - 400 093
Shantha Biotechnics
The Trend Setter
As the first Indian company to launch an r-DNA vaccine in 1997, Shantha heralded
a new beginning for biotechnology in India.
Shantha Biotechnics
Business: Research, development, manufacture and marketing of
biotechnology-based human health care products
CEO: KI Varaprasad Reddy
Biotech Revenue: Rs 115 crore
Start-up Year: 1993
Address: Serene Chambers, 3rd Floor, Banjara Hills, Road No. 7,
Hyderabad - 500 034
Eli Lilly and Company(India)
TB Fighter
Eli Lilly India has committed $50 million to fight Multi-Drug
Resistant Tuberculosis (MDR-TB).
Eli Lilly & Company (India)
Business: Marketing of pharmaceutical products
CEO: Sandeep Gupta (MD)
Biotech Revenue: Rs 112 crore
Start-up Year: 1993
Address: Plot No. 92, Sector 32, Institutional Area, Gurgaon - 122
001
Mahyco Seeds
Bt Cotton Pioneer
Established in 1964, Mahyco is a pioneer and leader in the Indian
seed industry.
Maharashtra Hybrid Seed Company Ltd
Business: Diagnostics solutions for GM crop testing
CEO: BR Barwale (Chairman)
Biotech Revenue: Rs 110.69 crore
Start-up Year: 1964
Address: PO Box 76, Jalna - Aurangabad Road, Dawalwadi,
Dist.- Jalna,
Maharashtra – 431203
Bharat Serums and Vaccines
Recombinant Therapeutics Player
Bharat Serums and Vaccines has been focusing on developing new
generation recombinant therapeutics that replace the traditional plasma products
Bharat Serums and Vaccines
Business: Manufacturing and marketing of biological products
CEO: Bharat Daftary (CMD)
Biotech Revenue: Rs 108.49 crore
Start-up Year: 1971
Address: 16th Floor, Hoechst House, Nariman Point, Mumbai - 400 021
Novozymes South Asia
Enzymatic Endeavors
Novozymes produces and sells more than 600 enzyme products in 130
different countries, the largest geographical markets being Europe,
North America and Asia.
Novozymes South Asia
Business: Industrial enzymes
CEO: GS Krishnan
Biotech Revenue: Rs 100 crore
Start-up Year: 2000
Address: #16, 7th Floor, Innovator, International Technology Park,
Whitefield Road, Bangalore - 560 066
Invert India
The Veterinarian
Intervet India is one of the largest MNCs in India dedicated to
animal health. It offers a range of products consisting of
biological, therapeutics and productive hormones.
Intervet India
Business: R&D and manufacturing of veterinary biological
CEO: Dr Lino Componovo (MD)
Biotech Revenue: Rs 80.58 crore
Start-up Year: 1997
Address: Intervet House, 33, Pune-Nagar Road, (Behind Eden Gardens), Pune - 411 014
Bharat Biotech International
Healthcare Specialist
Bharat Biotech was established in 1996 with the objective of manufacturing unique vaccines and biotherapeutics.
Bharat Biotech International
Business: Manufacturer of human vaccines and biopharmaceuticals
CEO: Dr Krishna M Ella
Biotech Revenue: Rs 70.27 crore
Start-up Year: 1996
New initiatives: Manufacture of human rabies vaccines, formulation of
various vaccines and biopharmaceuticals. Address: Road
No. 65 Jubilee Hills, Hyderabad
Ankur Seeds
Agribiotech Player
Ankur Seeds boasts of having over 115 hybrids in various crops. It
also has a large collection of proprietary germplasm with
novel traits of all crops.
Ankur Seeds
Business: Engaged in research, processing and developing
hybrid and Bt seeds
CEO: MG Shembekar (MD)
Biotech Revenue: Rs 69.50 crore
Start-up Year: 1976
Address: 27, New Cotton Market Layout, Nagpur - 440 018
Advanced Enzyme Technologies
The Catalyst
Advanced Enzyme Technologies produces enzymes and probiotics worth over $20
million annually and it is the largest manufacturer of serratiopeptidase.
Advanced Enzyme Technologies
Business: R&D, manufacturing and marketing of enzymes for different
industries
CEO: Chandrakant L Rathi (MD)
Biotech Revenue: Rs 69.30 crore
Start-up Year: 1958
Address: 5th Floor 'A' Wing Sun Magnetica, Galaxy Accolade, Next to LIC Building,
Service Road, Louis Wadi, Near Teen Hath Naka,Thane-(w)400604
Market Forecast
• According to the “India in Business”, Ministry of External Affairs, Govt of India the forecast for 2015 is that the Indian biotech industry would have an annual revenues in excess of US$13 billion
• According to Global Industry Analysis-The Biotechnology industry in India to reach $11.6 billion by 2017
Favorable Climate
• Indian Copyright Act, 1957• The Patent Act, 1970• Indian Patents and Design Act, 1972• The Trademarks Act, 1999• Biotechnology Patent Facilitating
Cell (BPFC)• Foundation of Biotechnology
Awareness and Education (FBAE)• National Research Development
Corporation (NRDC)